The Patent Finder

Placental Stem Cell Populations

Celeniv Pte. Ltd.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 3 of these applications claim priority to application 11/648,804, filed Dec 28, 2006. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 9,078,898Placental Stem Cell Populations
In force
 · High confidence
Celeniv Pte. Ltd.In force
High confidence
US 10,383,897Placental Stem Cell Populations
In force
 · High confidence
Celeniv Pte. Ltd.In force
High confidence
US 8,202,703Placental Stem Cell Populations
In force
 · High confidence
Celeniv Pte. Ltd.In force
High confidence
US 8,591,883Placental Stem Cell Populations
Lapsed Nov 26, 2025 on the fee record
Ended Nov 26, 2025 · High confidence
Celeniv Pte. Ltd.Lapsed Nov 26, 2025 on the fee recordEnded Nov 26, 2025
High confidence
US 8,691,217Placental Stem Cell Populations
Lapsed Apr 8, 2026 on the fee record
Ended Apr 8, 2026 · High confidence
Celeniv Pte. Ltd.Lapsed Apr 8, 2026 on the fee recordEnded Apr 8, 2026
High confidence
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
3 of these are in force and held by Celeniv Pte. Ltd..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited